Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20010796HPVENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TVIS20050995HPVENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TVIS20036611HPVENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TVIS20051062HPVENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TVIS44027007HTLV-1ENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TVIS44028203HTLV-1ENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TVIS44030086HTLV-1ENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TVIS44036379HTLV-1ENSG00000102572.15protein_codingSTK24NoNo8428B4DR80
Q6P0Y1
Q9Y6E0
TCGA Plot Options
Drug Information
GeneSTK24
DrugBank IDDB12010
Drug NameFostamatinib
Target IDBE0009383
UniProt IDQ9Y6E0
Regulation Typeinhibitor
PubMed IDs26516587
CitationsRolf MG, Curwen JO, Veldman-Jones M, Eberlein C, Wang J, Harmer A, Hellawell CJ, Braddock M: In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacol Res Perspect. 2015 Oct;3(5):e00175. doi: 10.1002/prp2.175. Epub 2015 Sep 4.
GroupsApproved; Investigational
Direct ClassificationMethoxyanilines
SMILESCOC1=CC(NC2=NC=C(F)C(NC3=NC4=C(OC(C)(C)C(=O)N4COP(O)(O)=O)C=C3)=N2)=CC(OC)=C1OC
Pathways
PharmGKB
ChEMBLCHEMBL2103830